HK Stock MarketDetailed Quotes

02487 CUTIA-B

Watchlist
  • 6.690
  • -0.130-1.91%
Market Closed Dec 24 12:08 CST
2.13BMarket Cap-3.71P/E (TTM)

About CUTIA-B Company

Established in 2019, we are a biopharmaceutical company driven by R&D and focusing on dermatology. We are committed to developing comprehensive solutions in a wide range of dermatology treatment and care markets to meet the ever-changing and diverse needs of patients and consumers. We have established a broad product portfolio targeting the four main areas of the broad dermatology treatment and care market, namely hair diseases and care, skin diseases and care, epidermal anesthesia, and topical fat accumulation management drugs. We also distribute several commercial products developed by overseas partners, and have launched several products in China. We are one of the few players with comprehensive comprehensive capabilities in the broad dermatology treatment and care market in China. We are customer-centric to improve candidate products and extend our comprehensive capabilities across the broad dermatology treatment and care industry value chain. Our platform covers everything from identifying requirements, developing core technology, managing clinical trials and early stages of product registration to product production and marketing. Our proprietary CATAME technology platform enables topical or transdermal administration of drugs by developing micron and nanoscale particles, evaluating the quality and stability of formulations, and performing dermal pharmacokinetic analysis. Our platform also helps design the most suitable dosage form, which is the key to specificity and successful administration. Through this platform, we have built a competitive product line for creams, sprays, ointments, aerosol foams, and other dosage forms.

Company Profile

Symbol02487
Company NameCUTIA-B
ISINKYG2606C1006
Listing DateJun 12, 2023
Issue Price21.85
Shares Offered21.28M share(s)
FoundedMay 15, 2019
Registered AddressCayman Islands
Chairmanlianyong chen
Secretaryshiting chen
Audit InstitutionErnst & Young
Company CategoryOther
Registered OfficeHarneys Fiduciary (Cayman) Limited 4th Floor, Harbour Place 103 South Church Street P.O. Box 10240 Grand Cayman KY1-1002 Cayman Islands
Head Office and Principal Place of Business5th Floor, Manulife Plaza, 348 Kwun Tong Road, Kowloon, Hong Kong
Fiscal Year Ends12-31
Employees360
MarketHong Kong motherboard
Phone(86)(21)52982688;(852)31809568
Emailpartnering@cutiatx.com;ir@cutiatx.com
Business Kodi Group is a Chinese company mainly engaged in the development and manufacture of dermatological biopharmaceuticals. The company is committed to developing comprehensive solutions to meet the diverse needs of patients and consumers in a wide range of dermatological treatment and care markets. The company is mainly engaged in clinical trials of its core product CU-20401. This product is mainly used to treat fat accumulation under the chin. The company operates in the Chinese domestic market and overseas markets.

Company Executives

  • Name
  • Position
  • Salary
  • lele zhang
  • CEOs, Executive Director, Founder, Authorized Representative
  • --
  • yuqing huang
  • Executive Director, Chief Financial Officer
  • --
  • lianyong chen
  • Chairman of the Board, Non-executive Directors, Chairman of the Nomination Committee, Remuneration Committee Members
  • --
  • qin xie
  • Non-executive Directors
  • --
  • xiao huang
  • Non-executive Directors
  • --
  • yunxia yang
  • Non-executive Directors
  • --
  • mingjie zhong
  • Independent Non-Executive Director, Chairman of the Audit Committee, Remuneration Committee Members, Nomination Committee Members
  • --
  • deren tao
  • Independent Non-Executive Director, Nomination Committee Members, Audit Committee Members
  • --
  • xiaoxiang ye
  • Independent Non-Executive Director, Remuneration Committee Chairman, Audit Committee Members
  • --
  • qi zhu
  • Chief Medical Officer
  • --
  • lei lei
  • Senior Vice President of R&D
  • --
  • chunna zhang
  • Senior Vice President of the Ministry of Pharmacy
  • --
  • jingxin xu
  • Senior Vice President of Production and Quality Control
  • --
  • jiaru wu
  • Senior Vice President of Finance and General Management
  • --
  • shiting chen
  • Authorized Representative, Company Secretary
  • --
Heat List
HK
Overall
Symbol
Price
% Chg

No Data